DUBLIN, May 6, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/52s9gq/oral_transmucosal) has announced the addition of the "Oral Transmucosal Drug Delivery to 2018" report to their offering.
In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs.
Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems.
Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. Growth in this sector will be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.
- Analyzes and evaluates oral transmucosal drug delivery technology platforms and their impact on the market
- Analyzes oral transmucosal drug products and pipeline product candidates
- Provides assessments of key oral transmucosal drug therapeutic categories
- Provides market data and forecasts to 2018
- Profiles market participants, their product development activities and strategies
Key Topics Covered:
Drug Delivery Market Dynamics
Evolution in Drug Development
Market and Demand Drivers
Shifting Patient Demographics
The Impact of Generics
Managed Care Initiatives
Competing Transmucosal Delivery Technologies
Buccal Films and Tablets
Sublingual Films and Wafers
Commercial Transmucosal Formulation Platforms
Oral Transmucosal Drug Technology Factors
FDA-Approved Oral Transmucosal Products
Serotonin 5-HT3 Inhibitors
Important Pipeline Product Candidates
Market Assessments & Forecasts
Formulations and Proprietary Platforms
Patent Expiration and Rx-to-OTC Switching
Market Participant Profiles
For more information visit http://www.researchandmarkets.com/research/52s9gq/oral_transmucosal
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets